These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
520 related items for PubMed ID: 15919175
1. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. Noji M, Kizu R, Takeda Y, Akiyama N, Yoshizaki I, Eriguchi M, Kidani Y. Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175 [Abstract] [Full Text] [Related]
2. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH, al-Baker S, Thai G, Khokhar AR. Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [Abstract] [Full Text] [Related]
3. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. Khokhar AR, al-Baker S, Shamsuddin S, Siddik ZH. J Med Chem; 1997 Jan 03; 40(1):112-6. PubMed ID: 9016335 [Abstract] [Full Text] [Related]
4. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y, Khokhar AR, al-Baker S, Siddik ZH. Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629 [Abstract] [Full Text] [Related]
5. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation. Hoeschele JD, Showalter HD, Kraker AJ, Elliott WL, Roberts BJ, Kampf JW. J Med Chem; 1994 Aug 19; 37(17):2630-6. PubMed ID: 8064793 [Abstract] [Full Text] [Related]
7. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs. Hacker MP, Khokhar AR, Brown DB, McCormack JJ, Krakoff IH. Cancer Res; 1985 Oct 19; 45(10):4748-53. PubMed ID: 4040806 [Abstract] [Full Text] [Related]
8. Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice. Saegusa Y, Eriguchi M, Kidani Y, Matsuzawa A, Takeda Y. Anticancer Res; 2001 Oct 19; 21(1A):245-52. PubMed ID: 11299742 [Abstract] [Full Text] [Related]
9. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K. Biol Chem; 1999 Nov 19; 380(11):1287-94. PubMed ID: 10614821 [Abstract] [Full Text] [Related]
10. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines. Yoshida M, Khokhar AR, Siddik ZH. Anticancer Drug Des; 1994 Oct 19; 9(5):425-34. PubMed ID: 7945726 [Abstract] [Full Text] [Related]
11. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV). Yoshida M, Khokhar AR, Siddik ZH. Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266 [Abstract] [Full Text] [Related]
12. Comparison of the effectivity of two diaminocyclohexane Pt-complexes. Balázová E, Hrubisko M, Ujházy V. Neoplasma; 1985 Sep 01; 32(5):537-42. PubMed ID: 4069288 [Abstract] [Full Text] [Related]
13. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J. J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031 [Abstract] [Full Text] [Related]
14. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand. Yamashita T, Hirose J, Noji M, Saito R, Tomida H, Kidani Y. Biol Pharm Bull; 1993 Oct 27; 16(10):1014-8. PubMed ID: 8287030 [Abstract] [Full Text] [Related]
15. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M, Khokhar AR, Siddik ZH. Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968 [Abstract] [Full Text] [Related]
16. Synthesis and biological activity of binuclear platinum complexes containing two monofunctional cis-[Pt(NH3)2Cl]+ units bridged by 4,4'-dipyridyl selenides or sulfides. Zhao G, Lin H, Zhu S, Sun H, Chen Y. Anticancer Drug Des; 1998 Oct 01; 13(7):769-77. PubMed ID: 9807161 [Abstract] [Full Text] [Related]
17. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line]. Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T. Gan To Kagaku Ryoho; 1990 Jan 01; 17(1):73-8. PubMed ID: 2404458 [Abstract] [Full Text] [Related]
18. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles. Komeda S, Takayama H, Suzuki T, Odani A, Yamori T, Chikuma M. Metallomics; 2013 May 01; 5(5):461-8. PubMed ID: 23608770 [Abstract] [Full Text] [Related]
19. Drug resistance induction and cross-resistance studies with Pt-complexes. Hrubisko M, Balázová E, Ujházy V. Neoplasma; 1984 May 01; 31(6):649-53. PubMed ID: 6542968 [Abstract] [Full Text] [Related]
20. Oxaliplatin activity in head and neck cancer cell lines. Espinosa M, Martinez M, Aguilar JL, Mota A, De la Garza JG, Maldonado V, Meléndez-Zajgla J. Cancer Chemother Pharmacol; 2005 Mar 01; 55(3):301-5. PubMed ID: 15619139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]